Business trending topics
8,970 results
Cenkos Securities Ltd reaffirmed their buy rating on shares of GlaxoSmithKline (LON: GSK) in a report issued on Monday, Stock Ratings Network reports. They currently have a GBX 1,933 ($29.71) target price on the stock.mideasttime.com · 1 day ago
In-depth coverage
GlaxoSmithKline (LON: GSK)‘s stock had its “underperform” rating reaffirmed by research analysts at BNP Paribas in a report released on Wednesday, StocKRatingsNetwork.com reports. They currently have a GBX 1 …utahpeoplespost.com · 1 day ago
In-depth coverageEXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass. TheStreet Ratings rates GlaxoSmithKline as a buy. The …MSN Money · 5/21/2013
Find out if (GSK) is in Cramer's Portfolio. Despite its growing revenue, the company underperformed as compared with the industry average of 6.7%. Since the same quarter one year prior, revenues slightly increased by 2.8%. This growth in revenue ...TheStreet.com · 5/14/2013
These expectations can be compared to the share price, to give you a better idea of how the stock market is valuing the business. Analysts expect GSK to earn 97 pence per share in 2013. Compared to today's share price of 1,720 pence, the market ...The Motley Fool · 5/21/2013
GlaxoSmithKline (LON: GSK)‘s stock had its “buy” rating reiterated by investment analysts at Cenkos Securities Ltd in a note issued to investors on Monday, Analyst Ratings Network reports. They currently have a …utahpeoplespost.com · 5/20/2013
Financial News Network Online
Wall St. Cheat Sheet
The stock’s 50-day moving average is currently GBX 1437.31. The company’s market cap is £82.711 billion. GlaxoSmithKline plc (LON: GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and …Zolmax News · 5/16/2013
In-depth coverageLONDON -- Successful investors use a disciplined approach to picking stocks, and checklists can be a great way to make sure you've covered all the bases. The pharmaceutical industry is riding a demographic wave of aging populations in developed …The Motley Fool · 4/10/2013
Jefferies International reiterated their hold rating on shares of GlaxoSmithKline (LON: GSK) in a research report sent to investors on Tuesday morning, AnalystRatings.Net reports. The firm currently has a GBX 1,550 ($23.78) price target on the stock.Zolmax News · 4/18/2013
How might earnings at GlaxoSmithKline plc (LON:GSK) change in the years to come? When weighing up a potential investment, it's useful to look forward rather than backwards. If you buy a stake in a business, it's the future profits that count -- and the ...Motley Fool UK · 5/20/2013
You might also like
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback